SEC Form 4 · accession 0001179110-15-008099
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Bowen
Officer — Chief Financial Officer
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par valueF3,F4 | May 15, 2015 | S | 5,637 | $67.6466 | D | 76,850 | D | |
| Common Stock, $.01 par valueF3,F5 | May 15, 2015 | S | 585 | $68.4559 | D | 76,265 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $15.92 | holding | — | — | — | Dec 22, 2009 | Dec 22, 2018 | Common Stock | 100,000 | 100,000 | D |
| Stock Option (right to buy)F1,F2 | $10.03 | holding | — | — | — | Jun 3, 2011 | Jun 3, 2020 | Common Stock | 7,500 | 7,500 | D |
| Stock Option (right to buy)F1,F2 | $22.44 | holding | — | — | — | May 22, 2013 | May 22, 2023 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy)F1,F2 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2024 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- F2These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
- F3Sale of common stock pursuant to reporting owner's 10b5-1 plan, including for payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- F4This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.0200 and $68.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.0200 and $68.6350. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.